1. Home
  2. NTHI
  3. NTHI News

Latest NeOnc Technologies Holdings Inc. Common Stock (NTHI) News on July 27, 2025

NTHI

Argus Research

a month ago

Daily – Vickers Top Insider Picks for 06/27/2025

NTHI

Argus Research

a month ago

Daily – Vickers Top Insider Picks for 06/26/2025

NeOnc Technologies Holdings Insiders Lose Out As Stock Sinks To US$3.72
NTHI

Simply Wall St.

a month ago

NeOnc Technologies Holdings Insiders Lose Out As Stock Sinks To US$3.72

NTHI

Argus Research

a month ago

Daily – Vickers Top Insider Picks for 06/25/2025

NTHI

Argus Research

a month ago

Daily – Vickers Top Insider Picks for 06/24/2025

NTHI

Argus Research

a month ago

Daily – Vickers Top Insider Picks for 06/23/2025

NTHI

Argus Research

a month ago

Daily – Vickers Top Insider Picks for 06/20/2025

NTHI

Argus Research

a month ago

Daily – Vickers Top Insider Picks for 06/18/2025

NTHI

Argus Research

a month ago

Daily – Vickers Top Insider Picks for 06/17/2025

NTHI

Argus Research

a month ago

Daily – Vickers Top Insider Picks for 06/16/2025

NTHI

Argus Research

a month ago

Daily – Vickers Top Insider Picks for 06/13/2025

NTHI

Argus Research

a month ago

Daily – Vickers Top Insider Picks for 06/12/2025

NTHI

Argus Research

2 months ago

Daily – Vickers Top Insider Picks for 06/11/2025

NTHI

Argus Research

2 months ago

Daily – Vickers Top Insider Picks for 06/10/2025

NTHI

MT Newswires

2 months ago

NeOnc Technologies Files Prospectus for Resale of Shares

NTHI

Argus Research

2 months ago

Daily – Vickers Top Insider Picks for 06/09/2025

NeOnc Technologies Holdings, Inc. Appoints Dr. Josh Neman as Chief Clinical Officer to Advance Clinical Strategy and Translational Oncology Programs
NTHI

GlobeNewswire

2 months ago

NeOnc Technologies Holdings, Inc. Appoints Dr. Josh Neman as Chief Clinical Officer to Advance Clinical Strategy and Translational Oncology Programs

NTHI

Argus Research

2 months ago

Daily – Vickers Top Insider Picks for 06/06/2025

NTHI

Argus Research

2 months ago

Daily – Vickers Top Insider Picks for 06/05/2025

NTHI

Argus Research

2 months ago

Daily – Vickers Top Insider Picks for 06/04/2025

NTHI

Argus Research

2 months ago

Daily – Vickers Top Insider Picks for 06/03/2025

NTHI

Argus Research

2 months ago

Daily – Vickers Top Insider Picks for 06/02/2025

NTHI

Argus Research

2 months ago

Daily – Vickers Top Insider Picks for 05/30/2025

NTHI

Argus Research

2 months ago

Daily – Vickers Top Insider Picks for 05/29/2025

NTHI

Argus Research

2 months ago

Daily – Vickers Top Insider Picks for 05/28/2025

NTHI

Argus Research

2 months ago

Daily – Vickers Top Insider Picks for 05/27/2025

NTHI

MT Newswires

3 months ago

Top Premarket Decliners

NeOnc Technologies Global Patent Portfolio Covers Core Pipeline Across All Major Pharmaceutical Markets
NTHI

GlobeNewswire

3 months ago

NeOnc Technologies Global Patent Portfolio Covers Core Pipeline Across All Major Pharmaceutical Markets

NTHI

MT Newswires

3 months ago

NeOnc Technologies Expects Full Enrollment in Phase 2a Trialfor NEO100-01 by September

NeOnc Technologies Holdings, Inc. Expects Full Enrollment in Promising Phase 2a Trial of NEO100-01 for Malignant Gliomas in September
NTHI

GlobeNewswire

3 months ago

NeOnc Technologies Holdings, Inc. Expects Full Enrollment in Promising Phase 2a Trial of NEO100-01 for Malignant Gliomas in September

NTHI

MT Newswires

4 months ago

NeOnc Technologies Appoints Executive Chairman Amir Heshmatpour as President

NeOnc Technologies Holdings, Inc. Executive Chairman, Amir Heshmatpour, Assumes Expanded Leadership Role as Company’s New President
NTHI

GlobeNewswire

4 months ago

NeOnc Technologies Holdings, Inc. Executive Chairman, Amir Heshmatpour, Assumes Expanded Leadership Role as Company’s New President

NTHI

MT Newswires

4 months ago

Sector Update: Health Care Stocks Fall Premarket Wednesday

NTHI

MT Newswires

4 months ago

NeOnc Technologies Phase 1 Trial Enrollment for NEO212 Brain Cancer Drug Nears Full Enrollment

NeOnc Technologies Announces Near Completion of Phase I Enrollment for NEO212 Brain Cancer Therapy
NTHI

GlobeNewswire

4 months ago

NeOnc Technologies Announces Near Completion of Phase I Enrollment for NEO212 Brain Cancer Therapy

NTHI

MT Newswires

4 months ago

NeOnc Technologies Holdings' Perillyl Alcohol Receives FDA's Rare Pediatric Disease Designation

NeOnc Technologies Holdings, Inc. Receives Rare Pediatric Disease Designation for NEO100 in Treatment of Pediatric-Type Diffuse High-Grade Gliomas
NTHI

GlobeNewswire

4 months ago

NeOnc Technologies Holdings, Inc. Receives Rare Pediatric Disease Designation for NEO100 in Treatment of Pediatric-Type Diffuse High-Grade Gliomas

NeOnc Technologies Expands Global Clinical Trial Network with CBCC Global Research to Accelerate Study of Brain Cancer Treatments
NTHI

GlobeNewswire

4 months ago

NeOnc Technologies Expands Global Clinical Trial Network with CBCC Global Research to Accelerate Study of Brain Cancer Treatments

Share on Social Networks: